Form 4: Xenon Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Steven Gannon, a Director of Xenon Pharmaceuticals Inc., sold 10,000 shares of common stock on August 11, 2026 for $64.06 per share.
Summary
- Open-market sale: disposed of 10,000 Common Shares at $64.06 ($640,550) on August 11, 2026; holds 1,870 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $640,550 of stock on the open market.
Insider Transactions
Steven Gannon — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Open-market sale | Common Shares | 10,000 | $64 | $640.5K | 1,870 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Open-market sale (10,000 shares) |
Keywords
insider transaction, Form 4, XENE, Xenon Pharmaceuticals Inc., bearish, Steven Gannon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.